Valorization of Morchella esculenta (Ascomycota) Using a Healthy Extraction Method: Investigation of Bioavailability, Anti-Acetylcholinesterase, and Antioxidant Potentials

Edible fungi are unexploited natural sources of high added value biomolecules, such as phenolic compounds. This study used an innovative and green extraction method based on the quick, easy, new, cheap, reproducible (QUENCHER) process of Morchella esculenta. The QUENCHER extract had a much higher concentration of total polyphenols [(125 mg gallic acid equivalents (GAE)/g dry weight (DW)], flavonoids [38 mg catechin equivalents (CE)/g DW], flavanols [22 mg quercetin equivalents (QE)/g DW], and proanthocyanidins [44 mg CE/g DW] than the traditional aqueous extraction. In addition, antioxidant activities were evaluated by the in vitro scavenging capacity of 1,1-diphenyl-2-picrylhydrazyl (DPPH) and iron reducing power. In the DPPH test, this phenolic richness clearly improved antioxidant activity, with an IC50 (inhibition concentration at 50%) of 0.097 mg/mL. It has also shown encouraging antibacterial qualities against resistant Gram-positive bacteria like Staphylococcus aureus (minimum inhibitory concentration varied between 6.25 and 25 μg/mL). For the acetylcholinesterase (AChE) inhibition, QUENCHER extract demonstrated strong AChE inhibition (IC50 = 0.002 mg/mL), a characteristic of significant interest in neurodegenerative disorders. These results open possibilities for using this extract as a natural antimicrobial agent, against resistant bacterial infections. Furthermore, in vitro digestion data indicates that the bioactive compounds in these extracts maintain relative stability during transit through the gastrointestinal tract, allowing for favorable bioavailability and, consequently, potential therapeutic efficacy. After 4 h of simulated digestion, over 66% of the antioxidant and anti-AChE activity was still present, indicating a degree of stability in the bioactive chemicals and an intriguing potential for bioavailability, according to in vitro digestibility experiments.

Authors

Institutions

Publication Details

Journal
International journal of medicinal mushrooms
Published
2025-01-01
DOI
https://doi.org/10.1615/intjmedmushrooms.2025059268
Citations
1
Primary Topic
Fungal Biology and Applications
Type
article
Field-Weighted Citation Impact
1.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Valorization of Morchella esculenta (Ascomycota) Using a Healthy Extraction Method: Investigation of Bioavailability, Anti-Acetylcholinesterase, and Antioxidant Potentials

Chedia Aouadhi, Mohamed Mendili, Ayda Khadhri, Arij Khemiri et al.
1 citations
International journal of medicinal mushrooms
Fungal Biology and Applications
1.39
article

Valorization of Morchella esculenta (Ascomycota) Using a Healthy Extraction Method: Investigation of Bioavailability, Anti-Acetylcholinesterase, and Antioxidant Potentials

Chedia Aouadhi, Mohamed Mendili, Ayda Khadhri, Arij Khemiri, chahrazed Jaffeli
article en
1 citations

Abstract

Edible fungi are unexploited natural sources of high added value biomolecules, such as phenolic compounds. This study used an innovative and green extraction method based on the quick, easy, new, cheap, reproducible (QUENCHER) process of Morchella esculenta. The QUENCHER extract had a much higher concentration of total polyphenols [(125 mg gallic acid equivalents (GAE)/g dry weight (DW)], flavonoids [38 mg catechin equivalents (CE)/g DW], flavanols [22 mg quercetin equivalents (QE)/g DW], and proanthocyanidins [44 mg CE/g DW] than the traditional aqueous extraction. In addition, antioxidant activities were evaluated by the in vitro scavenging capacity of 1,1-diphenyl-2-picrylhydrazyl (DPPH) and iron reducing power. In the DPPH test, this phenolic richness clearly improved antioxidant activity, with an IC50 (inhibition concentration at 50%) of 0.097 mg/mL. It has also shown encouraging antibacterial qualities against resistant Gram-positive bacteria like Staphylococcus aureus (minimum inhibitory concentration varied between 6.25 and 25 μg/mL). For the acetylcholinesterase (AChE) inhibition, QUENCHER extract demonstrated strong AChE inhibition (IC50 = 0.002 mg/mL), a characteristic of significant interest in neurodegenerative disorders. These results open possibilities for using this extract as a natural antimicrobial agent, against resistant bacterial infections. Furthermore, in vitro digestion data indicates that the bioactive compounds in these extracts maintain relative stability during transit through the gastrointestinal tract, allowing for favorable bioavailability and, consequently, potential therapeutic efficacy. After 4 h of simulated digestion, over 66% of the antioxidant and anti-AChE activity was still present, indicating a degree of stability in the bioactive chemicals and an intriguing potential for bioavailability, according to in vitro digestibility experiments.

International journal of medicinal mushroomsVol. 27(9)
Tunis University (TN), Instituto de Fisiología Vegetal (AR), Institut Pasteur de Tunis (TN), Tunis El Manar University (TN)
Zero hunger
Openalex Percentile: Top 22%
Fungal Biology and Applications
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.